QTRX.NASDAQQuanterix CORP

Form 4: Quanterix CFO Sriram Reports RSU Conversions

Sentiment:

Insider Transaction Report


Quanterix CFO Vandana Sriram reported the conversion of restricted stock units into common stock and subsequent tax-related dispositions.

Summary

  • Vandana Sriram, Chief Financial Officer of Quanterix Corp (QTRX), reported transactions involving common stock and restricted stock units (RSUs).
  • On March 15, 2026, 263 restricted stock units converted into 263 shares of common stock.
  • Concurrently, 93 shares of common stock were disposed of at a price of $4.72 per share to cover tax obligations.
  • An additional 514 restricted stock units converted into 514 shares of common stock on the same date.
  • Following this, 181 shares of common stock were disposed of at $4.72 per share for tax purposes.
  • A further 1,056 restricted stock units converted into 1,056 shares of common stock.
  • Subsequently, 371 shares of common stock were disposed of at $4.72 per share to satisfy tax liabilities.
  • Following these transactions, Vandana Sriram beneficially owns 27,428 shares of common stock directly.
  • Remaining derivative holdings include 4,471, 11,825, and 36,978 restricted stock units from grants on August 21, 2023, February 2, 2024, and February 4, 2025, respectively.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. The vesting of equity awards is a routine part of executive compensation, aligning management's interests with shareholders, while tax-related sales are a common consequence of such vesting.

Positives

  • The vesting and conversion of restricted stock units indicate the continued alignment of executive incentives with shareholder interests.
  • The transactions are part of a pre-established equity compensation plan, reflecting routine compensation practices.

Negatives

  • The disposition of common stock to cover tax liabilities reduces the direct shareholdings of the Chief Financial Officer.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports past insider transactions.

Industry Context

StockSavvy.ai notes that insider transaction reports like this Form 4 are standard disclosures for publicly traded companies. They provide transparency into executive stock ownership and compensation but typically do not reflect broader industry trends or competitive positioning. The vesting of RSUs is a common practice in the biotechnology and diagnostics industry to retain key talent.

Stakeholder Impact

  • Shareholders: Provides transparency on executive stock ownership and compensation, but the routine nature of these transactions is unlikely to have a significant impact on share price or company strategy.
  • Employees: Reflects standard executive compensation practices, which may indirectly influence employee morale and retention strategies.

Next Steps

  • Future vesting of remaining restricted stock units will occur according to their respective schedules (25% on the first anniversary of grant date, then 6.25% monthly thereafter).

Key Dates

DateDescription
August 21, 2023Vandana Sriram was granted 12,624 restricted stock units, vesting 25% on the first anniversary and 6.25% monthly thereafter. Also, Power of Attorney was executed by Vandana Sriram.
February 2, 2024Vandana Sriram was granted 24,675 restricted stock units, vesting 25% on the first anniversary and 6.25% monthly thereafter.
February 4, 2025Vandana Sriram was granted 50,712 restricted stock units, vesting 25% on the first anniversary and 6.25% monthly thereafter.
March 15, 2026Date of reported transactions, including conversion of restricted stock units to common stock and tax-related dispositions.
March 16, 2026Signature date of the Form 4 filing by Attorney-in-Fact.

Recommendation

hold

A Form 4 filing primarily reports insider transactions and does not provide sufficient information regarding the company's operational performance, financial health, or strategic outlook to warrant a change in investment recommendation. These are routine, pre-scheduled transactions related to executive compensation.

Keywords

QTRX, Quanterix, Form 4, Insider Transaction, Restricted Stock Units, CFO, Vandana Sriram, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.